We have a long history of developing innovative molecular technologies for cell line characterization and lot release testing for the biopharmaceutical industry. Our innovation continues with the BioReliance® Blazar™ platform, a novel degenerate PCR assay for the detection of a broad range of adventitious agents. Powered by the advantages of sensitivity, accuracy, and faster results and combined with the ability to detect a very broad range of viruses, this platform is well suited to cell line characterization and bulk-harvest lot release testing.
We are committed to accelerate testing and help the industry reduce the use of animal models. We have developed a rodent virus panel for the BioReliance® Blazar™ platform. This rodent virus panel provides a suitable alternative to the current in vivo MAP/HAP/RAP test that eliminates the need for animals.